Actavis Completes Forest Laboratories Acquisition LEARN MORE>
Actavis Completes Forest Laboratories Acquisition
>Go!

Educational Grants

Unrestricted Educational Grants

Allergan recognizes the importance of independent medical education programs that enhance the level of patient care in the United States. As such, Allergan funds educational activities through its extensive unrestricted educational grant program to foster increased understanding of scientific, clinical, or health care issues. We seek to provide an efficient and effective grant review process to help facilitate grant requests for quality independent education.

Allergan operates under the highest ethical standards and in full compliance with all applicable laws, regulations, and guidelines. Approval of grant funding is never related to or conditioned upon past prescriptions or purchases of Allergan products. Furthermore, Allergan does not offer or provide educational grants to encourage or to reward the prescription, purchase, ordering, or recommending of Allergan products.

Our grant approval process is in accordance with the recommendations and the guidance of the Office of Inspector General Compliance Program Guidance for Pharmaceutical Manufacturers (PhRMA), the Accreditation Council for Continuing Medical Education Guidelines, the PhRMA Code on Interaction with Health Care Professionals, the AdvaMed Code of Ethics on Interactions with Health Care Providers, as well as internal Allergan policies.

To begin the Allergan Medical Education grant process, please select a box below for the appropriate therapeutic area.

FRXIS

  • Alzheimer’s disease
  • Cardiovascular – Hypertension
  • Gastrointestinal Disease – Irritable Bowel Syndrome (with diarrhea or with constipation)
  • Infectious Disease – Bacterial Resistance
  • Psychiatric Disorders – Bipolar Disease, Schizophrenia, Major Depressive Disorder
  • Women’s Health

Visiontracker

  • Chronic Migraine
  • Medical Aesthetics
  • Neurology
  • Ophthalmology – Chronic Dry Eye, Glaucoma, Retinal Disease
  • Urology – Overactive Bladder
Call for Grant Notification

RFP ID: CFG WH 01
RFP Issue Date: January 26, 2016
Therapeutic Area: Women’s Health
Request for Proposal:  Live satellite symposium  (Multi-support encouraged)
Deadline for Submission of Application: February 19, 2016

Call for Grant Notification

RFP ID: CFG GI 02
RFP Issue Date: February 2, 2016
Therapeutic Area: Irritable bowel syndrome (IBS)
Request for Proposal:  Live satellite symposium  (Multi-support encouraged)
Deadline for Submission of Application: February 26, 2016